Keratinocyte and follicular epithelial cell components

Keratinocyte and follicular epithelial cell components refer to the collective structural and functional elements of the cells that form the epidermis and hair follicles. These components include essential proteins such as keratins and desmogleins, as well as signaling receptors like the keratinocyte growth factor receptor (FGFR2b), which are vital for skin integrity and hair growth cycles. In pathological states, these components often serve as the primary targets of autoimmune attacks, as seen in alopecia areata where the immune system targets the hair follicle, or in pemphigus where it targets keratinocyte adhesion molecules. Therapeutically, these components are targeted by a variety of agents to either stimulate growth or suppress immune-mediated damage. For example, minoxidil acts directly on these cells to promote proliferation and extend the anagen (growth) phase of the hair cycle, while JAK inhibitors are used to protect follicular cells from inflammatory cytokines. Because this term encompasses a broad range of molecules and cell types rather than a single protein, it is often used in a descriptive sense in clinical and pharmacological contexts to define the site of drug action or the focus of an immune response.

Other names

Keratinocyte antigensFollicular antigensHair follicle componentsEpidermal and follicular proteinsKeratinocyte and hair follicle epithelial cells

Drugs targeting these components work through various mechanisms: Minoxidil stimulates the proliferation of keratinocytes and follicular cells by opening ATP-sensitive potassium channels; Finasteride inhibits 5-alpha reductase to reduce dihydrotestosterone (DHT) levels that otherwise suppress follicular growth; JAK inhibitors (e.g., Tofacitinib) block the cytokine signaling (IFN-gamma, IL-15) that drives autoimmune destruction of follicular cells; and Corticosteroids suppress the inflammatory and autoimmune responses directed at these cellular components.